Latest Regulatory News

Energy Resources of Australia has pushed back its critical Pit 3 capping schedule by about 14 months and flagged a potential A$25 million to A$95 million increase in Ranger rehabilitation costs. The warning comes as ERA burns A$62.3 million in quarterly operating cash and awaits a November appeal hearing over Rio Tinto’s compulsory acquisition.

Strike Resources swung to an $8.58 million FY2026 profit, largely through its stake in LE Minerals rather than iron ore operations. The company is also relying on a conditional Apurimac sale for cash while withdrawing its previously reported mineral resource estimate.

Bulletin Resources has shifted its exploration focus further towards Lake Rebecca after reporting a $569,632 loss for the year, with Chifley drilling pointing to a possible concealed gold source but stopping well short of a discovery. The company ended June with $13.5 million in cash and listed investments, although its exploration portfolio still carries permitting and funding risks.

Starpharma has submitted its European trial application for DEP HER2-Lu and completed manufacture of clinical material, bringing its lead radiopharmaceutical closer to first patient dosing. The biotech also took control of Petalion, collected a Radiopharm option fee and finished the quarter with AUD $34.4 million in cash.

TradeWindow has signed a 12-month agreement to provide its Prodoc export documentation software across Lactalis’ Australian and New Zealand operations. The contract is described as being of significant value, although its financial contribution remains undisclosed.

Minbos Resources spent A$4.7 million on plant and equipment as construction advanced at its Cabinda phosphate project in Angola. The company also completed a post-quarter A$6 million placement, but BFA funding and approvals remain key dependencies for its Q2 2027 commissioning target.

Recce Pharmaceuticals has granted Arrotex exclusive rights to commercialise its investigational RECCE 327 topical gel in Australia and New Zealand. The agreement offers a potential profit-share stream, but no upfront payments, sales forecast or approval have been disclosed.

Australian Oil has moved its Surat Basin restart strategy closer to production, with Emu Apple-1 producing about 14 barrels of oil a day without water and Major-4 preparations advancing. The company ended the quarter with A$1.415 million in cash after raising A$1.404 million, but reported funding of about 2.7 quarters at its current outgoings.

Santos has reached the production and cash-flow inflection point it promised, posting record third-quarter output and approximately US$1.069 billion in free cash flow from operations. But Pikka’s commissioning interruptions have narrowed full-year guidance just as the company takes on more Papua LNG exposure.

Tivan Limited (ASX:TVN) is moving several projects towards major technical and financing milestones, including a proposed $50 million Molyhil joint venture and maiden drilling in Timor-Leste. The company ended September with $19.925 million in cash, equivalent to about 2.3 quarters of funding at the quarter’s reported spending rate.

Karoon Energy more than doubled quarterly production to 2.27 million barrels of oil equivalent as revenue climbed 64% to US$191.6 million. But the SPS-92 electrical fault remains unresolved, while the company balances growth spending, shareholder returns and US$269.2 million of net debt.

ABx Group says manufacture of the major equipment for its ALCORE hydrogen fluoride pilot plant is substantially complete, while electrical and civil works continue at Bell Bay in Tasmania. EPA Tasmania has accepted the project’s Environmental Effects Report for final assessment, but planning approval and commissioning remain ahead.